BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $9.6 billion as of May 19, 2026. Its market cap has decreased by -19.75% in one year.

Market Cap

9.60B

Enterprise Value

8.82B

1-Year Change

-19.75%

Ranking

#954

Market Cap Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $9.60B, an increase of 2,065.19%. That is a compound annual growth rate of 12.15%.

Market Cap History

Date	Market Cap	% Change
May 15, 2026	10.01B	-12.29%
Dec 31, 2025	11.42B	-8.86%
Dec 31, 2024	12.53B	-31.03%
Dec 29, 2023	18.16B	-5.57%
Dec 30, 2022	19.23B	18.58%
Dec 31, 2021	16.22B	1.90%
Dec 31, 2020	15.92B	4.81%
Dec 31, 2019	15.19B	0.17%
Dec 31, 2018	15.16B	-3.18%
Dec 29, 2017	15.66B	9.92%
Dec 30, 2016	14.25B	-15.66%
Dec 31, 2015	16.89B	26.72%
Dec 31, 2014	13.33B	33.25%
Dec 31, 2013	10.00B	64.58%
Dec 31, 2012	6.08B	54.81%
Dec 30, 2011	3.93B	42.26%
Dec 31, 2010	2.76B	45.68%
Dec 31, 2009	1.89B	6.63%
Dec 31, 2008	1.78B	-48.15%
Dec 31, 2007	3.43B	128.90%
Dec 29, 2006	1.50B	87.98%
Dec 30, 2005	796.50M	93.28%
Dec 31, 2004	412.10M	-16.92%
Dec 31, 2003	496.00M	31.08%
Dec 31, 2002	378.40M	-36.33%

View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Ionis Pharmaceuticals	12.05B
Madrigal Pharmaceuticals	11.86B
Axsome Therapeutics	11.73B
Arrowhead Pharmaceuticals	10.57B
Cytokinetics	10.23B
ABIVAX Société Anonyme	9.11B
Praxis Precision Medicines	9.03B
Krystal Biotech	8.90B

Market Cap Rankings